Genoptix Shares Rise as Novartis Plans Acquisition

Shares of Genoptix Inc. jumped 26 percent in premarket trading Monday after Swiss drug maker Novartis AG said it will pay $470 million to acquire the U.S. cancer diagnostic specialist.
MSN